SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-057549
Filing Date
2020-05-06
Accepted
2020-05-06 17:26:23
Documents
61
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q espr-20200331x10q.htm   iXBRL 10-Q 1158523
2 EXHIBIT 31.1 espr-20200331xex31d1.htm EX-31.1 13287
3 EXHIBIT 31.2 espr-20200331xex31d2.htm EX-31.2 12726
4 EXHIBIT 32.1 espr-20200331xex32d1.htm EX-32.1 9006
  Complete submission text file 0001104659-20-057549.txt   5633325

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA espr-20200331.xsd EX-101.SCH 45040
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE espr-20200331_cal.xml EX-101.CAL 50944
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE espr-20200331_def.xml EX-101.DEF 164243
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE espr-20200331_lab.xml EX-101.LAB 444843
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE espr-20200331_pre.xml EX-101.PRE 304463
55 EXTRACTED XBRL INSTANCE DOCUMENT espr-20200331x10q_htm.xml XML 1001326
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35986 | Film No.: 20853739
SIC: 2834 Pharmaceutical Preparations